StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck diluted EPS ($) ($)

Postgres DB financial_values

QuarterlyAnnual
Latest, Q2 2026
-0.54
Period ended Jun 30, 2026
Change on a year earlier
-130.7%
1.76 in Q2 2025
History
51 quarters
Since Q2 2008
Sources
48
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDiluted EPS ($) ($)Year on yearSource
Q2 2026Jun 30, 2026-0.54-130.7%Form 10-Q (filed 2026-08-07) ↗
Q1 2026Mar 31, 2026-1.72-185.6%Form 10-Q (filed 2026-05-04) ↗
Q3 2025Sep 30, 20252.32+87.1%Form 10-Q (filed 2025-11-05) ↗
Q2 2025Jun 30, 20251.76-17.8%Form 10-Q (filed 2025-08-05) ↗
Q1 2025Mar 31, 20252.01+7.5%Form 10-Q (filed 2025-05-02) ↗
Q3 2024Sep 30, 20241.24-33.3%Form 10-Q (filed 2024-11-06) ↗
Q2 2024Jun 30, 20242.14-191.1%Form 10-Q (filed 2024-08-05) ↗
Q1 2024Mar 31, 20241.87+68.5%Form 10-Q (filed 2024-05-03) ↗
Q3 2023Sep 30, 20231.86+45.3%Form 10-Q (filed 2023-11-03) ↗
Q2 2023Jun 30, 2023-2.35-251.6%Form 10-Q (filed 2023-08-07) ↗
Q1 2023Mar 31, 20231.11-34.7%Form 10-Q (filed 2023-05-05) ↗
Q3 2022Sep 30, 20221.28-28.9%Form 10-Q (filed 2022-11-03) ↗
Q2 2022Jun 30, 20221.55+154.1%Form 10-Q (filed 2022-08-05) ↗
Q1 2022Mar 31, 20221.70+36.0%Form 10-Q (filed 2022-05-05) ↗
Q3 2021Sep 30, 20211.80+55.2%Form 10-Q (filed 2021-11-05) ↗
Q2 2021Jun 30, 20210.61-48.3%Form 10-Q (filed 2021-08-09) ↗

Cite this data

StockData. (2026). Merck Diluted EPS ($) ($), quarterly Q2 2008–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_inc_eps_d

See every metric in the Merck KPI table. Data updated Oct 26, 2026.